Seminars in Oncology
Volume 31, Issue 5 , Pages 593-594 , October 2004

Current issues in diagnosis and treatment of primary and metastatic brain tumors

  • Jan C. Buckner (Guest Editor)

      Affiliations

    • Division of Medical Oncology, Mayo Clinic, Rochester, MN.
    • Corresponding Author InformationAddress reprint requests to Jan C. Buckner, MD, Mayo Clinic, Division of Medical Oncology, 200 First St SW, Rochester, MN 55905.

References 

  1. CBTRUS Statistical Report. Primary Brain Tumors in the United States, 1995–1999 . Hinsdale, IL: Central Brain Tumor Registry of the United States; 2002;
  2. Davis FG , Kupelian V , Freels S , et al.   Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups . Neurooncology . 2001;3:152–158
  3. Preston-Martin S . Epidemiology . In:  Berger MS ,  Wilson CB editor. The Gliomas . Philadelphia, PA: Saunders; 1999;p. 2–11
  4. Buckner JC . Factors influencing survival in high-grade gliomas . Semin Oncol . 2003;30(suppl 19):10–14
  5. Rood BR , MacDonald TJ , Packer RJ . Current treatment of medulloblastoma (Recent advances and future challenges) . Semin Oncol . 2004;31:666–675
  6. van den Bent MJ . Diagnosis and management of oligodendroglioma . Semin Oncol . 2004;31:645–652
  7. DeAngelis L , Hormigo A . Treatment of primary central nervous system lymphoma . Semin Oncol . 2004;31:684–692
  8. Keles GE , Berger MS . Advances in neurosurgical technique in the current management of brain tumors . Semin Oncol . 2004;31:659–665
  9. Bradley KA , Mehta MP . Management of brain metastases . Semin Oncol . 2004;31:693–701
  10. Matsutani M . Clinical management of primary central nervous system germ cell tumors . Semin Oncol . 2004;31:676–683
  11. Rao RD , James CD . Altered molecular pathways in gliomas (An overview of clinically relevant issues) . Semin Oncol . 2004;31:595–604

PII: S0093-7754(04)00323-9

doi: 10.1053/j.seminoncol.2004.07.001

Seminars in Oncology
Volume 31, Issue 5 , Pages 593-594 , October 2004